“In simple terms, the Ebola virus compromises the body's natural immune response to its presence, and we are seeking to develop molecules to counter that effect.”
— Stewart Schneller
An Auburn University research team, led by professor
of chemistry and biochemistry Stewart Schneller,
has produced a new drug candidate that could one
day slow or even stop the deadly Ebola virus. The
group of postdoctoral associates, PhD candidates,
and undergraduates designed a compound aimed
at reversing the immune-blocking abilities of certain
viruses, including Ebola.
This focused research and expertise represents a
decade of collaboration, perseverance, and continuous
improvement on results. This is WY3161, the Auburn-developed
compound under extensive study in
partnership with the National Institutes of Health.
Schneller directs his team in pursuing antiviral drug design and discovery with a focus on emerging and re-emerging viruses like monkeypox, measles, yellow
fever, West Nile Fever, dengue fever, and Hepatitis C.
Read the story...
Auburn helped prepare you for work and life with a solid foundation. Where has your Auburn education taken you? How has it changed you?
Share your images, stories, and posts with us by tagging @AuburnU or using the #thisisauburn hashtag. You can also email us at email@example.com. You may be featured in our next Auburn University ad campaign.